If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 81 - 90 of 278
The Effect of Intraoperative Brain Stimulation on Hand Strength and Function During Awake Craniotomies
Objective
Intraoperative Hand Function
Protocol No
IIT-KRUCOFF-INTRAOP-HAND-FUNC
Categories
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung
Objective
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Protocol No
INF-AN2-EBO-301-MAC
Categories
Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for Treatment of Human Orthopoxvirus Infections (CDC IND 116039, CDC IRB Protocol #6402)
Objective
TPOXX for Treatment of Human Orthopoxvirus Infections
Protocol No
INF-CDC-TPOXX-EA-IND-MONKEYPOX
Categories
A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion with rHuPH20, in Combination with CAB LA to Standard of Care in Vi
Objective
HIV Embrace
Protocol No
INF-GSK-EMBRACE-HIV
Categories
A Multicenter, Adaptive, Randomized, Controlled, Trial Platform to Evaluate Safety and Efficacy Strategies and Treatments for Hospitalized Patients with Respiratory Infections
Objective
Safety, Efficacy and Tx Strategies for Hospitalized Patients with Respiratory Infections
Protocol No
INF-NIAID-STRIVE
Categories
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)
Objective
Study Evaluating Safety and Efficacy of JCAR017 in Subject with rrCLL or SLL
Protocol No
JUNO-017004-TRANSCEND-CLL
Categories
A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy
Objective
Zanubrutinib in Primary Membranous Nephropathy
Protocol No
NEPH-BEIGENE-BGB-3111-309
Categories
A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 12 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Objective
VX-147 in APOL1- Mediated Proteinuric Kidney Disease
Protocol No
NEPH-VERTEX-VX21-147-301
Categories
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
Objective
Registry of Patients with AQP4+ NMOSD Treated with Alexion C5 Inhibitor Therapies
Protocol No
NEURO-ALEXION-ALX-NMO-501
A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multip
Objective
BIIB091 and BIIB091 Combined with Diroximel Fumarate in Relapsing MS
Protocol No
NEURO-BIOGEN-FUSION